Hernandez-Pacheco, N.* ; Kilanowski, A. ; Kumar, A.* ; Curtin, J.A.* ; Olvera, N.* ; Kress, S.* ; Bertels, X.* ; Lahousse, L.* ; Bhatta, L.* ; Granell, R.* ; Marí, S.* ; Bilbao, J.R.* ; Sun, Y.* ; Tingskov Pedersen, C.E.* ; Karramass, T.* ; Thiering, E. ; Dardani, C.* ; Kebede Merid, S.* ; Wang, G.* ; Hallberg, J.* ; Koch, S.* ; Garcia-Aymerich, J.* ; Esplugues, A.* ; Torrent, M.* ; Ibarluzea, J.* ; Lowe, L.* ; Simpson, A.* ; Gehring, U.* ; Vermeulen, R.C.H.* ; Roberts, G.* ; Bergström, A.* ; Vonk, J.M.* ; Felix, J.F.* ; Duijts, L.* ; Bønnelykke, K.* ; Timpson, N.* ; Brusselle, G.* ; Brumpton, B.M.* ; Langhammer, A.* ; Turner, S.* ; Holloway, J.W.* ; Arshad, S.H.* ; Ullah, A.* ; Custovic, A.* ; Cullinan, P.* ; Murray, C.S.* ; van den Berge, M.* ; Kull, I.* ; Schikowski, T.* ; Wedzicha, J.A.* ; Koppelman, G.* ; Faner, R.* ; Agustí, À.* ; Standl, M. ; Melén, E.*
     
 
    
        
Exploring the genetics of airflow limitation in lung function across the lifespan – a polygenic risk score study.
    
    
        
    
    
        
        EClinicalMedicine 75:102731 (2024)
    
    
    
		
		
			
				Background: Chronic obstructive pulmonary disease (COPD) is caused by interactions between many factors across the life course, including genetics. A proportion of COPD may be due to reduced lung growth in childhood. We hypothesized that a polygenic risk score (PRS) for COPD is associated with lower lung function already in childhood and up to adulthood. Methods: A weighted PRS was calculated based on the 82 association signals (p ≤ 5 × 10−8) revealed by the largest GWAS of airflow limitation (defined as COPD) to date. This PRS was tested in association with lung function measures (FEV1, FVC, and FEV1/FVC) in subjects aged 4–50 years from 16 independent cohorts participating in the Chronic Airway Diseases Early Stratification (CADSET) Clinical Research Collaboration. Age-stratified meta-analyses were conducted combining the results from each cohort (n = 45,406). These findings were validated in subjects >50 years old. Findings: We found significant associations between the PRS for airflow limitation and: (1) lower pre-bronchodilator FEV1/FVC from school age (7–10 years; β: −0.13 z-scores per one PRS z-score increase [–0.15, −0.11], q-value = 7.04 × 10−53) to adulthood (41–50 years; β: −0.16 [–0.19, −0.13], q-value = 1.31 × 10−24); and (2) lower FEV1 (from school age: 7–10 years; β: −0.07 [–0.09, −0.05], q-value = 1.65 × 10−9, to adulthood: 41–50 years; β: −0.17 [–0.20, −0.13], q-value = 4.48 x 10−20). No effect modification by smoking, sex, or a diagnosis of asthma was observed. Interpretation: We provide evidence that a higher genetic risk for COPD is linked to lower lung function from childhood onwards. Funding: This study was supported by CADSET, a Clinical Research Collaboration of the European Respiratory Society.
			
			
				
			
		 
		
			
				
					
					Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Scopus
Cited By
					
					Altmetric
					
				 
				
			 
		 
		
     
    
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
    
        Typ der Hochschulschrift
        
    
 
    
        Herausgeber
        
    
    
        Schlagwörter
        Chronic Obstructive Pulmonary Disease ; Genetics ; Lung Function ; Polygenic Risk Score; Obstructive Pulmonary-disease; Genome-wide Association; Heritability; Prediction; Spirometry; Phenotypes
    
 
    
        Keywords plus
        
    
 
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2024
    
 
    
        Prepublished im Jahr 
        0
    
 
    
        HGF-Berichtsjahr
        2024
    
 
    
    
        ISSN (print) / ISBN
        2589-5370
    
 
    
        e-ISSN
        2589-5370
    
 
    
        ISBN
        
    
 
    
        Bandtitel
        
    
 
    
        Konferenztitel
        
    
 
	
        Konferzenzdatum
        
    
     
	
        Konferenzort
        
    
 
	
        Konferenzband
        
    
 
     
		
    
        Quellenangaben
        
	    Band: 75,  
	    Heft: ,  
	    Seiten: ,  
	    Artikelnummer: 102731 
	    Supplement: ,  
	
    
 
  
        
            Reihe
            
        
 
        
            Verlag
            Springer
        
 
        
            Verlagsort
            Radarweg 29, 1043 Nx Amsterdam, Netherlands
        
 
	
        
            Tag d. mündl. Prüfung
            0000-00-00
        
 
        
            Betreuer
            
        
 
        
            Gutachter
            
        
 
        
            Prüfer
            
        
 
        
            Topic
            
        
 
	
        
            Hochschule
            
        
 
        
            Hochschulort
            
        
 
        
            Fakultät
            
        
 
    
        
            Veröffentlichungsdatum
            0000-00-00
        
 
         
        
            Anmeldedatum
            0000-00-00
        
 
        
            Anmelder/Inhaber
            
        
 
        
            weitere Inhaber
            
        
 
        
            Anmeldeland
            
        
 
        
            Priorität
            
        
 
    
        Begutachtungsstatus
        Peer reviewed
    
 
    
        Institut(e)
        Institute of Epidemiology (EPI)
    
 
    
        POF Topic(s)
        30202 - Environmental Health
    
 
    
        Forschungsfeld(er)
        Genetics and Epidemiology
    
 
    
        PSP-Element(e)
        G-504000-008
    
 
    
        Förderungen
        Region Stockholm (ALF)
Provincial Government of Gipuzkoa
Basque Department of Health
ERDF
Instituto de Salud Carlos III
Swedish Heart-Lung Foundation
Swedish Research Council
Netherlands Ministry of Health, Welfare, and Sport
Netherlands Ministry of Spatial Planning, Housing
Lung Foun-dation Netherlands
Netherlands Organisation for Scientific Research
Netherlands Organisation for Health Research and Development
Norwegian Institute of Public Health
Central Norway Regional Health Authority
HUNT Research Centre (Faculty of Medicine and Health Sciences at Norwegian University of Science and Technology (NTNU))
Generalitat de Catalunya through the CERCA Program
State Research Agency through the "Centro de Excelencia Severo Ochoa
Spanish Ministry of Science and Innovation
Conselleria de Sanitat Gen-eralitat Valenciana
Netherlands Organisation of Scientific Research NWO Investments
Erasmus MC, Rotterdam, The Netherlands
Municipality of Rotterdam
Ministry for Health, Welfare and Sports, the European Commission (DG XII)
Ministry of Education, Culture, and Science
Research Institute for Diseases in the Elderly (RIDE)
University of Bristol - Erasmus Medical Center and Erasmus Uni-versity, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw)
Wellcome
David Hide Asthma and Allergy Research Trust
Asthma UK
National Institutes of Health USA
UK Medical Research Council
Analysis of Ashford, ALSPAC
Federal Ministry of Education and Research (BMBF)
Genetic Laboratory of the Depart-ment of Internal Medicine, Erasmus MC
Research Institute for Diseases in the Elderly
Spanish Biomedical Research Center in Epidemiology and Public Health (CIBERESP)
Netherlands Genomics Initiative (NGI) /Netherlands Organisation for Scientific Research (NWO) Netherlands Consortium for Healthy Aging (NCHA)
Generalitat de Catalunya through the CERCA Program - Ministry of Culture and Science of North Rhine-Westphalia (MKW)
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2024-09-10